April 11, 2025

Gilead Sciences Celebrates 2023 with ESG Recognition

Community Resource Consultants Inc. (CRCI)

Community Resource Consultants Inc. (CRCI) is a Michigan-based organization specializing in trauma rehabilitation medical case management. With over 34 years of experience, CRCI is dedicated to empowering survivors of catastrophic auto accidents to regain control of their lives and achieve both physical and emotional well-being. Their team of Licensed Master Social Workers (LMSWs) and Registered Nurses (RNs) are experts in navigating the complexities of today’s healthcare system, ensuring that survivors receive the necessary services for their recovery and rehabilitation. CRCI’s core values include advocacy, people, knowledge, and dependability, reflecting their commitment to being leading advocates and facilitators of long-term collaborative care.

News Summary

Gilead Sciences has been recognized for its commitment to Environmental, Social, and Governance (ESG) practices by patient advocacy groups globally. In 2023, the company has focused on accessing vital therapies for HIV, viral hepatitis, and COVID-19 through voluntary licensing, shown dedication to diversity and inclusion within the workplace, and contributed significantly to philanthropic efforts worldwide. With a strong employee retention rate and advancements in climate responsibility, Gilead stands out as a leader in corporate responsibility, earning high ratings from patient groups on ESG practices.

Gilead Sciences Shines Bright in 2023 with ESG Recognition!

In a world where corporate responsibility is becoming more important than ever, Gilead Sciences has made quite a splash this year. The company has been acknowledged for its commitment to Environmental, Social, and Governance (ESG) practices by patient advocacy groups across the globe. This recognition comes as a testament to Gilead’s dedication to accessing crucial therapies and maintaining high ethical standards in their operations.

Accessing Vital Therapies

Gilead has been working diligently to ensure that people have the access they need to life-saving treatments for HIV, viral hepatitis, and COVID-19. Through what they call voluntary licensing, Gilead has made strides in enabling access to these vital therapies throughout 2023. Furthermore, the company has been hosting educational sessions with healthcare providers to spread awareness and improve patient care.

FOCUS on Testing

For over a decade now, the FOCUS program has been at the forefront of testing for HIV and viral hepatitis, showing Gilead’s long-term commitment to these critical health issues since its inception in 2010. With consistent advancements in testing and preventive measures, Gilead continues to showcase its resolve in tackling these global health challenges.

Diversity Takes Center Stage

As diversity and inclusion become buzzwords in the corporate landscape, Gilead is leading by example. Since 2022, the company has been pouring funds into diverse suppliers and supporting clinical trial grants that foster diversity. This spending in 2023 is a clear indicator of their commitment to fostering a more inclusive environment—not just within the company, but throughout their entire supply chain.

Giving Back Globally

Philanthropy is at the heart of Gilead’s operations. Their global donations in 2023 reflect a significant effort to give back and support communities worldwide. This generosity has earned the company a stellar reputation among organizations that focus on social issues, particularly in the healthcare domain.

Employee Wellbeing and Engagement

Gilead doesn’t just care about the outside world; their employees matter just as much. With a remarkable 95%+ employee retention rate, including an impressive 96% for top performers, Gilead is clearly doing something right internally. The recognition of their Employee Wellbeing Center with LEED Platinum Certification is a cherry on top!

Climate Responsibility

This year, Gilead also snagged the title of a CDP Supplier Engagement Leader for taking noteworthy actions aimed at reducing climate risk. This step reassures not just employees but also patients and other stakeholders that Gilead is committed to a sustainable future.

A Friendly Competition

In a survey conducted by PatientView, Gilead was rated as the “best” in ESG among pharmaceutical companies that patient groups have worked with. Companies like Roche and AstraZeneca took the next spots, but Gilead still stands out for their impressive commitment to society.

Looking Ahead

There’s more to be expected! The data on these impressive initiatives is updated annually, with another round of updates set to roll out in April 2025. However, like any responsible company, Gilead acknowledges that there’s always room for improvement. Patient groups have suggested clearer communication about their ESG efforts and more practical actions to back up their claims.

Political Transparency

Gilead’s high ranking on the Zicklin Political Accountability Scorecard emphasizes its commitment to transparency and ethical governance—a critical factor we’re seeing more and more companies adopt.

Final Thoughts

Overall, Gilead Sciences is celebrating a stellar 2023 filled with accolades for its ESG practices, strong employee engagement, and commitments to social responsibility. These efforts reflect a broader trend among pharma companies to take their responsibilities seriously and advocate for a healthier and fairer world. As patient advocacy groups campaign for continued accountability, it’s clear Gilead is a name to watch in the future!